Compare HCAT & BTCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HCAT | BTCS |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Finance: Consumer Services |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.0M | 148.0M |
| IPO Year | 2019 | N/A |
| Metric | HCAT | BTCS |
|---|---|---|
| Price | $2.36 | $3.19 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | $4.30 | ★ $7.00 |
| AVG Volume (30 Days) | 741.0K | ★ 1.2M |
| Earning Date | 11-10-2025 | 11-14-2025 |
| Dividend Yield | N/A | ★ 1.67% |
| EPS Growth | N/A | ★ 644.42 |
| EPS | N/A | ★ 1.76 |
| Revenue | ★ $316,063,000.00 | $11,724,983.00 |
| Revenue This Year | $3.23 | $248.05 |
| Revenue Next Year | N/A | $41.01 |
| P/E Ratio | ★ N/A | $1.70 |
| Revenue Growth | 4.63 | ★ 464.28 |
| 52 Week Low | $2.02 | $1.25 |
| 52 Week High | $8.00 | $8.49 |
| Indicator | HCAT | BTCS |
|---|---|---|
| Relative Strength Index (RSI) | 39.10 | 50.29 |
| Support Level | $2.33 | $3.28 |
| Resistance Level | $2.51 | $3.26 |
| Average True Range (ATR) | 0.14 | 0.25 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 5.65 | 45.71 |
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
BTCS Inc. ("BTCS" or the "Company"), short for Blockchain Technology Consensus Solutions, is a U.S.-based Ethereum-first blockchain technology company committed to driving scalable revenue and ETH accumulation through its hallmark strategy, the DeFi/TradFi Accretion Flywheel, an integrated approach to capital formation and blockchain infrastructure. By combining decentralized finance ("DeFi") and traditional finance ("TradFi") mechanisms with its blockchain infrastructure operations, comprising NodeOps (staking) and Builder+ (block building), BTCS offers one of the most sophisticated opportunities for leveraged ETH exposure, driven by scalable revenue generation and a yield-focused ETH accumulation strategy. Discover how BTCS offers operational and financial leveraged exposure to Ethereum through the public markets at www.btcs.com.